Tag: rectalcancer
-
PROGRESS Study Expands Clinical Partnership to Advance Prediction of Radiotherapy Response in Rectal Cancer
Oncosyne is pleased to welcome Haukeland University Hospital as a new clinical partner in the PROGRESS study, joining Akershus University Hospital in investigating whether patient-derived tumoroids can predict radiotherapy response in rectal cancer. The PROGRESS study aims to evaluate whether functional testing of patient-derived tumoroids can help predict how individual patients will respond to radiotherapy…